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Roles for specialty societies and vascular surgeons
in accountable care organizations
Philip P. Goodney, MD, MS,a,b Elliott S. Fisher, MD, MPH,b and Richard P. Cambria, MD,c Hanover,
NH; and Boston, Mass
With the passage of the Affordable Care Act, accountable care organizations (ACOs) represent a new paradigm in
healthcare payment reform. Designed to limit growth in spending while preserving quality, these organizations aim to
incant physicians to lower costs by returning a portion of the savings realized by cost-effective, evidence-based care back
to the ACO. In this review, first, we will explore the development of ACOs within the context of prior attempts to control
Medicare spending, such as the sustainable growth rate and managed care organizations. Second, we describe the
evolution of ACOs, the demonstration projects that established their feasibility, and their current organizational
structure. Third, because quality metrics are central to the use and implementation of ACOs, we describe current efforts
to design, collect, and interpret quality metrics in vascular surgery. And fourth, because a “seat at the table” will be an
important key to success for vascular surgeons in these efforts, we discuss how vascular surgeons can participate and lead
efforts within ACOs. (J Vasc Surg 2012;55:875-82.)
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dWith the passage of the Affordable Care Act in 2010,1
a new payment model was created for Medicare patients
who receive their healthcare within large health systems.
Most patients undergoing major vascular surgery in the
United States are over age 65, and accordingly, the major-
ity of these patients receive Medicare benefits. Therefore,
these changes in the manner by which Medicare payments
are determined will affect a significant portion of the pa-
tients cared for by vascular surgeons, a population whose
vascular care is estimated to cost $5 billion dollars annu-
ally.2
According to the Center for Medicare and Medicaid
Services, the main goal of the Affordable Care Act is to
improve health care quality and slow spending growth in
Medicare.1 However, many remain concerned about how,
why, and where accountable care organizations (ACOs)
will change the manner in which vascular health care is
provided. In this review, we summarize the development of
ACOs, explore the roles of subspecialty societies and data
registries within ACOs, and examine opportunities for vas-
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ONTROLLING MEDICARE SPENDING IN
ECENT YEARS: THE SUSTAINABLE GROWTH
ATE, MANAGED CARE, AND THE
VOLUTION OF ACOs
The Affordable Care Act was passed by Congress on
eptember 17, 20103 and signed by President Obama on
ecember 14, 2010.4 A key element of this legislation was
provision that encouraged the development of a new
atient care model, the accountable care organization. This
erm was introduced by Fisher and others in 2006,5 in
esponse to ongoing attempts by Congress to limit Medi-
are spending, given the commonly held belief that current
rends in Medicare spending are unsustainable.6
In the 1990s, the main tool used to limit spending was
he sustainable growth rate (SGR) program.7,8 Many sur-
eons will recognize the term “sustainable growth rate
SGR),” an acronym commonly mentioned in the lay press
nd popular media during heavily publicized debates in
ongress9 regarding physician payments for services to
edicare payments. The SGR was originally created and
mplemented in 1997 as a mechanism to report and limit
pending growth on physician services. But calculating the
ormula and enacting legislation for fee reduction were
esigned as two different actions, and Congress has found
t difficult to execute the latter goal. In response to political
ressure, Congress began to pass cost reductions on to
uture years. Importantly, when failing to deal with an
ncrease in Medicare spending in any one year, the “bur-
en” of decision making (and the excess costs) are passed
n to the next year. These effects become cumulative over
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reduction of over 20% would be necessary to deal with
several years of deferrals.10,11
The political evolution of ACOs began in the 1990s,
not only due to the lack of efficacy of the SGR in limiting
growth but also because managed care organizations also
encountered difficulty in achieving cost savings.7 While the
reasons underlying the failure of managed care in the 1990s
are debated, many believe that these organizations failed
because they relied on two flawed strategies to limit expen-
ditures.12 First, at the patient level, payers attempted to
limit access to services. Copays, complex referral require-
ments, and preauthorizations were all used by insurers to
make access to care (especially expensive specialty care)
difficult. Second, at the provider level, payers attempted to
negotiate lower payments with individual providers and
introduced risk-sharing models such as capitation. While
these arrangements encouraged providers to remain “ac-
countable” for the care provided to patients, quality of care
was not considered in the relationship between patient care
and provider.
Why did these strategies fail? First, as payers attempted
to put these plans into everyday use, patients were generally
unwilling to accept purely capitated payment models, pri-
marily because of questions regarding the underlying phy-
sician motivation in making treatment decisions (“why
doesn’t my doctor want to fixmy aneurysm?”).13 Addition-
ally, providers felt they were unable to lower costs without
being perceived by patients as “rationing care.”14 Debate
ensured in attempts to find a way to reduce cost,15 and
ACOs emerged as the next possible solution.
Seeking to learn from this experience, policymakers
developed a new concept of shared risk (and responsibility)
for this care between insurers and providers. “Shared risk,”
wherein the provider and insurer share the financial respon-
sibility surrounding care, is a central tenet in the concept of
ACOs. In this concept, performance measurement and
quality markers are used to reward physicians and hospitals
that provide cost-effective, evidence-based care.5 Policy-
makers argue that key differences exist between ACOs in
today’s healthcare environment and managed care plans of
the past. By limiting spending, ACO participants who
achieve cost savings retain a portion of the proceeds saved.
But unlike traditional managed care plans, quality measures
Table I. Criteria for designation as an accountable care or
Criteria for desi
Express willingness to be accountable for quality, cost, and overall
years
Have a formal legal structure to receive and distribute shared savin
Have at least 5000 assigned beneficiaries with a sufficient number
Report on quality, cost, and care coordination measures, and mee
May initially focus on one-sided shared savings modelsexist to align patient and provider interests and incentives. pARLY EXPERIENCE IN ACOs: THE
HYSICIAN GROUP PRACTICE
EMONSTRATION PROJECT AND THE
DVOCATE PHYSICIAN PARTNERS
Once the conceptual model of quality at lower cost and
rovider accountability was established, policymakers be-
an outlining the criteria that would define ACOs. Broadly,
s outlined in theMedicare shared savings program,3 ACOs
re groups of physicians, hospitals, or care systems estab-
ished within Medicare, that “take responsibility for the
ost and quality of care received by patients, and these
rganizations will receive a share of the savings they achieve
or Medicare.”16 Medicare will include organizations that
eet several key criteria (shown in Table I) in this program,
hich begins January 1, 2012. CMS has dedicated $10
illion toward this effort from FY2011 through FY2019,
emonstrating a long-term commitment to the implemen-
ation, study, and refinement of this newmethod of health-
are payment management.17
By intent, the ACO criteria shown in Table I are
exible, to allow conformability to local markets. However,
arge, established multispecialty care systems that directly
mploy physicians within a group practice model and al-
eady had an administrative infrastructure capable of quality
easurement were ideal settings in which to pilot this
odel of healthcare. Two widely studied, large experimen-
al efforts have been performed in these settings, and early
esults have been promising (Table II).
First, a CMS-sponsored demonstration project, enti-
led the Physician Group Practice Demonstration (PGP),
tudied 10 large, distinct multispecialty groups between
pril 2005 and December 2009.18,19 These groups varied
n size from small group practices to large multispecialty
linics, ranging from 232 to 1291 physicians and were
roadly distributed across different regions of the United
tates. In each site, an ACO was established, quality mea-
ures were defined, and projected spending targets were set
ased on prior years’ expenditures.
After 5 years in this project, all 10 PGP sites were able
o meet the majority (29 of the 32) of the quality goals
utlined in the project’s quality guidelines. Five of the
GPs generated a combined Medicare savings of $38.7
illion (compared with their projected Medicare spending
uring the same time period). These savings were achieved
y “increasing organizational efficiency, care management
ation (ACO)
on as an ACO
of Medicare fee-for-service beneficiaries for a minimum of 3
imary care ACO professionals
ent-centeredness criteria set forth by the HHS Secretaryganiz
gnati
care
gs
of pr
t patirograms (such as remote-based monitoring for chronic
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Volume 55, Number 3 Goodney et al 877diseases such as congestive heart failure, diabetes, and hy-
pertension), and education and feedback to providers
regarding populations of patients with given condi-
tions.”18-20 While a more precise cost accounting will likely
be necessary for surgeons to “buy into” this concept, this
demonstration project represents a starting point for these
organizations to use in their efforts to curtail spending. A
second example of how the ACO model can utilized has
been demonstrated by the Advocate Physician Partners in
Illinois.21 This partnership established an ACO contract
with the largest insurer in the region, Blue Cross/Blue
Shield. Across 3500 physicians in a large multispecialty
practice, the Advocate Physician Partners modified and
reinforced an existing complex organizational structure “to
improve care, cut costs, and be held accountable for the
results.” They cited changes in electronic medical records
and information technology, as well as physician leadership
in governance activities as central in generating cost sav-
ings. Further, they used a deliberate effort in continuously
selecting, removing, or modifying the 116 performance
measures designed to ensure quality in their organization.
In both of these efforts, obtaining positive results re-
quired large structural planning efforts and considerable
incentives toward organizational formation, extending well
beyond the typical Medicare fee-for-service model. Leaders
in ACO formation described three key elements as critical
to successful implementation. First, an advanced infrastruc-
ture, such as electronic medical records and an extensive
administrative structure with defined quality measures, was
used to drive physician and hospital performance. Second,
physicians and hospitals demonstrated sustained commit-
ment to improving performance. And third, regulatory
agencies and organizational administration allowed mech-
anisms within ACOs to allow provision of health care, as
well as provide the means necessary to measure and im-
Table II. Summary of physician group practice plan and a
Project/site Number of hospitals Number of physicians
N
Physician
Group
project
10 large group
practices
5000 physicians, ranging
from 232-1291 per
practice
Advocate
physician
partners
10 affiliated group
and private
practices
3500 physicians; 2700 in
group practice, 900 in
solo/independent
practice

ACO, Accountable care organization.prove health care delivery. hURRENT STATUS OF ACO STRUCTURE AND
RGANIZATION
In the standard fee-for-service Medicare payment
odel, CMS assumes the “financial risk” of health care
elivery, and health care expenditures have risen steadily
cross Medicare for several decades.22,23 Providers and
ospitals have few incentives to limit spending, and prior
ttempts to align payment with quality have been difficult
o design and implement.24 Therefore, ACOs were de-
igned to limit the financial exposure of the insurer, and
ncant the provider to meet quality goals and limit spend-
ng, and achieve their quality targets.
How will this be carried out in the real world? In the
implest models, initially piloted by CMS, current per cap-
ta spending in recent years for a given population within an
CO will be calculated utilizing existing Medicare claims
ata.5 Then, a future spending target will be negotiated
etween the payer for the ACO structure and the group of
roviders. These providers will then be “accountable” for
eeting spending targets, as well as satisfying predefined
uality metrics. After the conclusion of the year, if actual
pending is lower than target spending, and quality metrics
ave been achieved, then the “shared savings” are divided
etween CMS and the ACO. If actual spending exceeds
arget spending, providers are not held liable for these
dditional expenditures, but they also do not receive bonus
ayments like those derived from “shared savings.”
There are several paradigms, each along a continuum of
isk, that detail potential ways in which the ACOs will
anage risk (ie, who is responsible for cost overruns and
ho is rewarded with cost savings) (Table III). The “shared
avings” example provides the simplest example, at the
owest “risk” end of the spectrum. In the “shared savings”
lan, the provider assumes minimal risk, and existing
ate physician partners
er of
nts Primary payer
Examples of quality
markers
Savings returned to
ACO providers
,204 Center for
Medicare
services
● Beta blocker
therapy for post-
MI patients
$31.7 million
distributed back
to five sites that
met quality goals
● Documented
hypertension
Plan of care
,000 Blue Cross/
Blue Shield
● eICU capability
for all ICU beds
$38 million in
incentive
payments
distributed to
3700 physicians
across 10 sites
● Specified plan of
blood sugar,
cholesterol,
blood pressure
controldvoc
umb
patie
223
1,000ospital-based quality measures are used to measure deliv-
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March 2012878 Goodney et alery of care, allowing simplicity in measurement. First, pre-
dicted spending goals are established based on past perfor-
mance.Moving forward, if providers meet quality goals and
spend less than predicted, these “shared savings” are re-
turned to the providers. This system requires little upfront
capital or structural investment, complex organizational
support is not necessary, and quality measures can be simple
and hospital based (such as the rate of preoperative antibi-
otic administration). Most importantly, these initial ar-
rangements represent a single-sided approach to risk—
while providers are rewarded if savings are achieved, no
provider penalty is incurred if the cost of caring for the
cohort exceeds the target spending limit.
At the other end of this continuum, in terms of risk
management, are scenarios such as symmetric or partial
capitation payment models. These models expose the ACO
group to financial risk if spending goals are not achieved but
also allow the ACO to retain a greater share of savings if
goals are achieved.5 For example, in capitation-payment
models, the ACO provides advanced payment to the health
care system, and therefore the risk burden for the provision
of health care delivery rests with the organization. In this
model, reminiscent of capitation efforts piloted in the
1990s,25 more risk will be leveraged by the providers in the
ACOs, but they will also stand to gain a larger portion of
potential shared savings.26
Critics and proponents of the ACO concept agree that
several important pieces of this puzzle still have yet to be
defined.27 Other than the demonstration projects de-
scribed above, little evidence exists as to how the adminis-
trative elements of ACOs will be structured or created. It
also remains unclear how organizations will support the
significant upfront expenditures necessary to build the or-
ganizational, IT, and quality improvement infrastructure
needed to create an ACO. This sizeable investment will
likely limit ACO creation to large care systems where many
of these elements are already in existence, at least in the near
Table III. Payment models in accountable care organizati
Type of ACO structure Complexity Required infrastru
Simple shared savings Simplest Limited
Symmetric Moderate Complex regional cost tr
CATA required
Partial capitation Complex Cost tracking data requir
payment per plan partifuture. wWhat’s in it for vascular surgeons? The concern most
ertinent to vascular surgeons is how surgeon “productiv-
ty,” both in the sense of volume and quality, will correlate
o compensation derived from “shared savings” plans. Sur-
eons may end up employed by ACOs, or compete for
eferrals from groups of providers in an ACO. Those sur-
eons who elect to participate in an ACO organizational
tructure will undoubtedly be held to quality benchmarks
nd not simply be paid based on production or case vol-
me. New paradigms will evolve wherein surgeons, once
ncented by volume alone, will now be incented by quality-
ased metrics. The manner in which this evolution occurs
ill depend on two important variables: (1) the need and
vidence for the procedure which the surgeon performs,
nd (2) the quality metrics associated with the operation.
herefore, the responsibility of demonstrating the need
nd quality measures associated with each surgical proce-
ure we perform rests with surgeons, and accordingly,
urgeons must rise to a leadership role in this task.
HY QUALITY MEASURES WILL MATTER
While vascular surgeons in ACOswill be incentivized to
educe expenditures, they will also be responsible for en-
uring that quality surgical care is provided to address the
ascular health of the populations they serve. Therefore, a
ore component of ACO participation is the design, imple-
entation, and interpretation of quality metrics across
opulations of patients within the ACO.
Several examples of the design and use of quality met-
ics for general medical care exist in the Medicare Demon-
tration Project. For example, certain quality metrics in the
rizona ACO (Table II) were simple, plausible, concrete
nd points defined a priori within the structure of the
CO. In diabetes care, the ACO used frequency of blood
lucose monitoring as a quality measure. Similarly, in in-
ensive care unit (ICU) care, the participation of an inten-
ivist, either in person or via electronic ICU monitoring,
ACOs)
IF: quality targets are achieved
actual spending
projected spending Risk burden
Provider receives bonus Risks reside primarily
with payer
g Provider receives bonus if
savings occur. However,
provider liable for spending
that exceeds projections
Shared risk between
payer and
providers.
pfront
ts
Share of saving Shared risk, early
payment offers
support for
innovation
Distributed back to providers.
Larger potential to recover
savings, but also greater
risk if overspending occursons (
cture
ackin
ed, u
cipanas defined as a quality measure. In both measures, physi-
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Volume 55, Number 3 Goodney et al 879cians in the ACO demonstrated compliance with quality
metrics in these domains, and limited expenditures, earning
production bonuses.
For vascular patients, quality measures specific to the
care of populations with vascular disease will need to be
developed. With a history of leadership in total patient
care,28 patient advocacy for disease preventions,29,30 and
advanced organizational initiatives in quality measurement
improvement,31 vascular surgeons and the SVS stand in an
advantageous position to establish and validate quality
measures in vascular care. For example, the Society for
Vascular Surgery (SVS) has been active in producing guide-
lines for carotid disease,32 peripheral arterial disease,33 ve-
nous disease,34 and AAA/TAA,35,36 both within the SVS
and in broader forums such as the American Heart Associ-
ation (Table IV).
But, how will vascular surgeons find the time, organi-
zational structure, and practical tools necessary to become
voices within the structure of the ACO for vascular care?
We believe the answer to this question is twofold. First, as
the representative national vascular society, the SVS can
lead national efforts to establish guidelines for delivering
quality vascular care, especially in terms of more precisely
delineating the thresholds where intervention is appropri-
ate in conditions where variation exists, such as peripheral
vascular disease37 and carotid disease.38 Second, vascular
surgeons in both community and academic settings can
actively participate in quality improvement efforts and col-
laborate in multimodality approaches toward measuring
and improving quality in vascular surgery.
THE ROLE OF THE SVS IN ACOs
The first role the SVS can capitalize on is to further
clarify and endorse practice guidelines, especially wherein
evidence exists to support the formation of these docu-
ments. The SVS long ago initiated this endeavor (Table
IV). However, the scope of this work can be expanded.
Detailed observational data currently contained in regional
registries, such as the SVS Patient Safety Organization (SVS-
PSO) could be used to generate risk-adjusted, population-
specific benchmarks for intervention for carotid, aneurysms,
Table IV. Examples of clinical practice guidelines develop
Clinical problem Guidelines Exampl
Carotid disease JVS V-54 (3) pp e1-31
September 201165
Preferentia
(antiplat
asympto
60% st
Abdominal
aortic
aneurysm
JVS supplement October
200935
Routine fo
postimp
Lower extremity
peripheral
arterial disease
Hirsch et al. JACC 2006;
47:1-192.66
Exercise th
interven
claudica
CEAs, Carotid endarterectomies; EVAR, endovascular aortic repair; JVS, Jolower extremity bypass, and endovascular interventions. Fur- aher, after outlining acceptable rates of intervention, quality
easures in the performance of these procedures could be
stablished, catalogued, by the SVS.
In several ways, the SVS-PSO represents an ideal forum
o manage these tasks. Data collected in the SVS-PSO are
rotected from discovery or as “patient safety work prod-
ct,” do not require patient consent for inclusion and do
ot require IRB approval for collection. Further, CMS has
ncouraged the creation and implementation of novel ser-
ice deliverymodels such as this via the Center forMedicare
ndMedicaid Innovation, a clearinghouse for efforts to test
nd implement new payment and service delivery models.39
n settings wherein the management of disease remains
ontroversial, the SVS should continue to increase its role
n generating vital comparative effectiveness research. Ex-
mples of recent efforts in this regard are efforts to con-
truct clinical trials to determine the best patterns of prac-
ice in carotid stenting40,41 and claudication.42,43 While
ifficult and lengthy, efforts such as these will be critical in
uiding practice improvements.
OW VASCULAR SURGEONS CAN LEAD
UALITY EFFORTS IN ACOs
A key aspect of care delivery in an ACO is the definition
nd determination of quality of care. These steps require
uality measures, and the work of developing, validating,
nd implementing quality measures in vascular surgery
epresents a key role for vascular surgeons.
The notion of surgeons as leaders in national quality
mprovement efforts has been well established. For exam-
le, the Society for Thoracic Surgery (STS) database has
sed continuous quality improvement techniques to record
utcomes and use this information for quality improve-
ent for over 20 years.44 These measures have included
imple measures such as operative volume, or more com-
lex measures such as risk-adjusted CABG mortality or
enter-level proportion of renal failure following CABG
urgery. Each of these measures undergoes a specific vet-
ing process, wherein the impact, evidence, and potential
enefits toward improvements in quality are explored by a
orking group. Once implemented, these measures serve
d endorsed by the Society for Vascular Surgery
ecommendations Potential quality marker
of medical therapy
gents, statin) in
patients with
s
Less than 1% of all CEAs occurring in
asymptomatic patients with 60%
stenosis
up post-EVAR
ion
90% of surviving EVAR cases
undergo postimplantation imaging
within the first year
prior to
or patients with
Fewer than 10% of patients undergoing
peripheral intervention without 3
months of supervised exercise
therapy
of Vascular Surgery.ed an
es of r
l use
elet a
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llow-
lantat
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eral surgery have also served as platforms for quality mea-
surement. The American College of Surgeons National
Surgical Quality Improvement Program (ACS-NSQIP) has
been established as an effective vehicle wherein surgeons
can participate in national efforts in surgical quality im-
provement.46 Originally developed within the Veterans
Affairs system, NSQIP has established a generalizable, val-
idated, systematic approach to quality improvement in
surgery that has been successfully applied in hundreds of
federal, community, and academic centers across a variety
of surgical specialties.47
Finally, at least three efforts in defining quality mea-
sures and quality improvement have also taken place within
vascular surgery itself (Fig). First, the SVS has developed
and implemented the Vascular Registry and the Vascular
Quality Initiative, two important steps in quality measure-
ment.48 Focused on carotid revascularization, the Vascular
Registry was created to allow physicians treating patients
with carotid disease to monitor patient and procedural
details, record outcomes, and perform critically needed
comparative effectiveness research in carotid endarterec-
tomy and carotid stenting.49,50 Further, other studies of
“real-world” practice have been performed in vascular sur-
gery, using administrative, quality improvement or other
data sources to describe the use and outcomes of carotid
surgery,51,52 abdominal aortic aneurysm repair,53 with tho-
racic endovascular aortic repair (TEVAR),54 and lower
extremity revascularization.55 Vascular surgeons have used
regional quality improvement initiatives such as the Vascu-
lar Quality Initiative (VQI) to study and improve outcomes
across a variety of vascular procedures. For example, using
benchmarks for regional performance in carotid surgery,56
vascular surgeons in New England implemented programs
to increase the utilization of evidence-based processes of
care and demonstrated improved outcomes as a result.57
Moreover, these efforts in regional quality improvement
Leadership In
Vascular Po
Regional Quality 
Collaboratives (VQI)
bli h b h k f•Esta s enc mar s or
performance
•Implementation of evidenced-
based care
C i l ili i• ompare reg ona  ut zat on
rates
ACS-NS
•Effective, broadly dis
program across surgica
•National representatio
health policy
•Validated, endorsed w
by payers and policym
Fig. Potential mechanisms to participate in accountab
improvement.were applied in settings outside of the procedures them- “elves, extending into medical care of vascular patients.
sing the regional initiative as a platform, surgeons in New
ngland increased the use of adjunctive medications such
s perioperative -blockers,58 antiplatelet agents, and st-
tins.59 And third, the SVS has developed objective perfor-
ance goals (OPGs), or outcomes that define appropriate
uality measures in lower extremity revascularization.60,61
hese OPGs have been used both as benchmarks for clini-
al trials of new devices and therapies as well as establishing
oals for performance in community and academic set-
ings.60
UTURE CHALLENGES AND OPPORTUNITIES
Many surgeons will argue that an ACO, a quality
easurement tool, or a regional practice guideline repre-
ents an unnecessary and unwelcome change in their every-
ay practice. However, as these changes in health care
elivery in the United States proceed forward, an increase
n the level of oversight will undoubtedly occur.62 Fortu-
ately, the concept of surgeons leading specialty-specific
uality measurement within specialty organizations most
ertainly has precedent. Several prominent national organi-
ations offer quality assessment and quality measurement
evelopment in cardiology care, general surgery, and tho-
acic surgery. Therefore, it is incumbent upon the SVS and
ts members to lead this task for populations with vascular
isease.
These changes will not proceed without challenges.
irst, the structural and process of care changes necessary
ill take time and effort away from vascular surgeons, at a
ime when clinical, research, and teaching commitments
lready consume significant time and resources. However,
onparticipation on the part of the vascular surgical com-
unity will only leave this knowledge gap for others to fill.
ascular surgery was “forward-thinking” in endovascular
are, and the rapid and enthusiastic adoption of this
e Care  of 
lations
Disease-Specific Registries
•Specific focus on process such as 
h i (i SVSt orac c aneurysms .e.
Outcomes Committee TAA 
Dataset)
•Comparative effectiveness 
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in this instance.
Second, because of the significant expense of many of
the procedures we perform, vascular surgeons will have to
continue to perform high-quality cost-effectiveness re-
search that demonstrates the population-based value of
vascular surgery. Past efforts in carotid and aneurysm sur-
gery will need to be replicated in lower extremity revascu-
larization, most specifically in the use of endovascular ther-
apy in claudication42 and critical limb ischemia,60 as well as
in quality-of-life evaluation across vascular procedures. Fur-
ther, the use of the vascular laboratory in the management
of dialysis access, bypass graft maintenance, and carotid
imaging will all need to be delineated to accurately reflect
the value inherent in these procedures.
Lastly, vascular surgeons will need to continue to ex-
pand the role we play in improving the vascular health of
populations at risk, beyond our current procedurally based
efforts toward disease-based care. For example, we can take
a more active role in ensuring that our patients adhere to
evidence-based treatments such as antiplatelet agents, st-
atins, and beta blockers for those patients at high risk for
complications.63,64 Across these strategies, however, it is
vital that the SVS, as well as vascular surgeons in coordina-
tion with and from the Society, continue to participate and
lead efforts in ensuring that quality, appropriate vascular
care is provided to vascular patients.
AUTHOR CONTRIBUTIONS
Conception and design: PG
Analysis and interpretation: PG, EF, RC
Data collection: PG
Writing the article: PG
Critical revision of the article: PG, EF, RC
Final approval of the article: PG, EF, RC
Statistical analysis: PG
Obtained funding: PG
Overall responsibility: PG
REFERENCES
1. United States. Congress. House. Committee on Ways and Means,
United States. Congress. House. Committee on Energy and Com-
merce. United States. Congress. House. Committee on Education and
Labor. Compilation of Patient Protection and Affordable Care Act: as
amended through November 1, 2010 including Patient Protection and
Affordable Care Act health-related portions of the Health Care and
Education Reconciliation Act of 2010. Washington: U.S. Government
Printing Office; 2010.
2. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs
of peripheral arterial disease in the Medicare population. Vasc Med
2008;13:209-15.
3. Medicare Shared Savings Program. Available at: https://xteam.
brookings.edu/bdacoln/Documents/ACO%20Summit%20McClellan%
20final%20(June%207%202010).pdf_.
4. PresidentObama signs health care legislation into law.Available at: http://
www.nytimes.com/2010/03/24/health/policy/24health.html.
5. ACO Learning Network. Available at: http://acolearningnetwork.org.
6. Health care Reform. The New York Times 2011.
7. Sustainable Growth Rates in the Center For Medicare and Services.Available at: https://www.cms.gov/SustainableGRatesConFact/
Downloads/sgr2010p.pdf In CMS.gov.8. Facts About the Sustainable Growth Rate (Online information from the
Center for Medicare and Medicaid Services) Available at: https://
www.cms.gov/SustainableGRatesConFact/Downloads/sgr2010p.pdf.
9. Aaron HJ. The SGR for physician payment–an indispensable abomina-
tion. N Engl J Med 2010;363:403-5.
0. DoBias M. Try, try again. SGR fix on tap, but AMA ‘disappointed’ by
measure. Mod Health 2010;40:8-9.
1. Brown CA. What’s wrong with the SGR. Bull Am Coll Surg 2004;89:
8-11.
2. Robinson JC. The end of managed care. JAMA 2001;285:2622-8.
3. Rossiter LF, Langwell K, Wan TT, Rivnyak M. Patient satisfaction
among elderly enrollees and disenrollees in Medicare health mainte-
nance organizations. Results from the National Medicare Competition
Evaluation. JAMA 1989;262:57-63.
4. Crawshaw R. Health care rationing. Oregon asked people about moral
values. BMJ 1996;312:1229-30.
5. Blumenthal D. Controlling health care expenditures. N Engl J Med
2001;344:766-9.
6. Archives of the United States Senate: Health Care Reform Bill 2010
Available at: http://dpc.senate.gov/healthreformbill/healthbill04.pdf.
7. Stephanie Cutter. What repealing the Affordable Care Act will cost
families, seniors, small businesses, states; January 15, 2011. Available at:
http://www.whitehouse.gov/blog/2011/01/05/what-repealing-
affordable-care-act-will-cost-families-seniors-small-businesses-state.
8. Iglehart JK. Assessing an ACO Prototype - Medicare’s Physician Group
Practice Demonstration. N Engl J Med 2010.
9. CMS trumpets PGP demonstration successes. Manag Advis D 2008:
14:1–6.
0. Kautter J, Pope GC, Trisolini M, Grund S. Medicare physician group
practice demonstration design: quality and efficiency pay-for-
performance. Health Care Financ Rev 2007;29:15-29.
1. Shields MC, Patel PH, Manning M, Sacks L. A model for integrating
independent physicians into accountable care organizations. Health Aff
(Millwood) 2011;30:161-72.
2. Skinner J, Chandra A, Goodman D, Fisher ES. The elusive connection
between health care spending and quality. Health Aff (Millwood)
2009;28:w119-23.
3. Fisher ES, Wennberg JE, Stukel TA, Sharp SM. Hospital readmission
rates for cohorts of Medicare beneficiaries in Boston and New Haven.
N Engl J Med 1994;331:989-95.
4. Wennberg JE, Bronner K, Skinner JS, Fisher ES, Goodman DC.
Inpatient care intensity and patients’ ratings of their hospital experi-
ences. Health Aff (Millwood) 2009;28:103-12.
5. Robinson JC. Reinvention of health insurance in the consumer era.
JAMA 2004;291:1880-6.
6. Fisher ES. Building a medical neighborhood for the medical home.
N Engl J Med 2008;359:1202-5.
7. Iglehart JK. Assessing an ACO prototype–Medicare. N Engl J Med
2011;364:198-200.
8. Plummer D, Macsata R, Sidawy AN. Training in vascular medicine for
vascular surgeons–what is it and how will we accomplish it? Semin Vasc
Surg 2006;19:200-4.
9. Wells D. Welcome to Medicare visit and AAA screening. Fam Pract
Manag 2007;14:16; Author reply.
0. Silverstein MD, Pitts SR, Chaikof EL, Ballard DJ. Abdominal aortic aneu-
rysm (AAA): cost-effectiveness of screening, surveillance of intermediate-
sized AAA, and management of symptomatic AAA. Proc (Bayl Univ Med
Cent) 2005;18:345-67.
1. Vascular Quality Initiative. Available at: http://www.vascularweb.org/
practiceresources/vascular-quality-initiative/Pages/default.aspx. Accessed
January 23, 2012.
2. BrottTG,Halperin JL,Abbara S, et al. ASA/ACCF/AHA/AANN/AANS/
ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the
Management of Patients with Extracranial Carotid and Vertebral Artery Dis-
ease: Executive Summary: A Report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice Guidelines,
and the American Stroke Association, American Association of Neuroscience
nurses, American Association of Neurological Surgeons, American College of
Radiology, American Society of Neuroradiology, Congress of Neurological
Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for
55
5
5
5
5
5
5
5
6
6
6
6
6
6
6
JOURNAL OF VASCULAR SURGERY
March 2012882 Goodney et alCardiovascular Angiography and Interventions, Society of Interventional
Radiology, Society of NeuroInterventional Surgery, Society for Vascular
Medicine, and Society for Vascular Surgery. Circulation 2011;2011.
33. Olin JW, Allie DE, Belkin M, et al. ACCF/AHA/ACR/SCAI/SIR/
SVM/SVN/SVS 2010 performance measures for adults with peripheral
artery disease: a report of the American College of Cardiology Foundation/
American Heart Association Task Force on Performance Measures. the
American College of Radiology, the Society for Cardiac Angiography
and Interventions, the Society for Interventional Radiology, the Society
for Vascular Medicine, the Society for Vascular Nursing and the Society
for Vascular Surgery (Writing Committee to Develop Clinical Perfor-
mance Measures for Peripheral Artery Disease). J Am Coll Cardiol
2010;56:2147-81.
34. Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with
varicose veins and associated chronic venous diseases: clinical practice
guidelines of the Society for Vascular Surgery and the American Venous
Forum. J Vasc Surg 2011;53:2S-48S.
35. Chaikof EL, Brewster DC, Dalman RL, et al. The care of patients with
an abdominal aortic aneurysm: the Society for Vascular Surgery practice
guidelines. J Vasc Surg 2009;50:S2-49.
36. Hodgson KJ, Matsumura JS, Ascher E, et al. Clinical competence state-
ment on thoracic endovascular aortic repair (TEVAR)–multispecialty con-
sensus recommendations. A report of the SVS/SIR/SCAI/SVMB Writ-
ing Committee to develop a clinical competence standard for TEVAR. J
Vasc Surg 2006;43:858-62.
37. Goodney PP. Variation in the use of invasive revascularization for severe
lower extremity PAD in the year prior to amputation. Chicago, IL:
Society for Vascular Surgery; 2011.
38. Goodney PP, Travis LL, Malenka D, et al. Regional variation in carotid
artery stenting and endarterectomy in the Medicare population. Circ
Cardiovasc Qual Outcomes 2010;3:15-24.
39. Center for Medicare and Medicaid Innovation. Available at: http://
innovations.cms.gov/about-us/the-opportunity/. Accessed August
22, 2011.
40. Brott TG, Hobson RW II, Howard G, et al. Stenting versus endarter-
ectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;
363:11-23.
41. Rudarakanchana N, Dialynas M, Halliday A. Asymptomatic Carotid
Surgery Trial-2 (ACST-2): rationale for a randomised clinical trial
comparing carotid endarterectomy with carotid artery stenting in pa-
tients with asymptomatic carotid artery stenosis. Eur J Vasc Endovasc
Surg 2009;38:239-42.
42. Murphy TP, Hirsch AT, Cutlip DE, et al. Claudication: exercise vs
endoluminal revascularization (CLEVER) study update. J Vasc Surg
2009;50:942-5 e2.
43. Farber A, Menard M. The BEST trial: a comparison of open and
endovascular treatment of lower extremity PAD. J Vasc Surg 2011;
(abstract submitted to SVS 2011).
44. National Quality Forum. Available at: http://www.nationalqualityforum.
com.
45. Peterson ED, Coombs LP, DeLong ER, Haan CK, Ferguson TB.
Procedural volume as a marker of quality for CABG surgery. JAMA
2004;291:195-201.
46. Itani KM. Fifteen years of the National Surgical Quality Improvement
Program in review. Am J Surg 2009;198:S9-S18.
47. Hall BL, Richards K, Ingraham A, Ko CY. New approaches to the
National Surgical Quality Improvement Program: the American Col-
lege of Surgeons experience. Am J Surg 2009;198:S56-62.
48. The Vascular Registry Available at: http://www.vascularweb.org/
practiceresources/Pages/vascular-registry.aspx.
49. Sidawy AN, Zwolak RM, White RA, Siami FS, Schermerhorn ML,
Sicard GA, et al. Risk-adjusted 30-day outcomes of carotid stenting and
endarterectomy: results from the SVS Vascular Registry. J Vasc Surg
2009;49:71-9.50. White RA, Sicard GA, Zwolak RM, et al. Society of vascular surgery
vascular registry comparison of carotid artery stenting outcomes for Satherosclerotic vs nonatherosclerotic carotid artery disease. J Vasc Surg
2010;51:1116-23.
1. Kresowik TF, Bratzler DW, Kresowik RA, et al. Multistate improve-
ment in process and outcomes of carotid endarterectomy. J Vasc Surg
2004;39:372-80.
2. MuradMH, Shahrour A, Shah ND,Montori VM, Ricotta JJ. A system-
atic review and meta-analysis of randomized trials of carotid endarter-
ectomy vs stenting. J Vasc Surg 2011;53:792-7.
3. Schermerhorn ML, O’Malley AJ, Jhaveri A, Cotterill P, Pomposelli F,
Landon BE. Endovascular vs. open repair of abdominal aortic aneu-
rysms in the Medicare population. N Engl J Med 2008;358:464-74.
4. ConradMF, Ergul EA, Patel VI, Paruchuri V, Kwolek CJ, Cambria RP.
Management of diseases of the descending thoracic aorta in the endo-
vascular era: a Medicare population study. Ann Surg 2010;252:603-10.
5. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National
trends in lower extremity bypass surgery, endovascular interventions,
and major amputations. J Vasc Surg 2009;50:54-60.
6. Goodney PP, Likosky DS, Cronenwett JL, Vascular Study Group of
Northern New England. Factors associated with stroke or death after
carotid endarterectomy in Northern New England. J Vasc Surg 2008;
48:1139-45.
7. Goodney PP, Nolan BW, Eldrup-Jorgensen J, Likosky DS, Cronenwett
JL, Vascular Study Group of Northern New England. Restenosis after
carotid endarterectomy in a multicenter regional registry. J Vasc Surg
2010;52:897-904, 5 e1-2; discussion -5.
8. Goodney PP, Eldrup-Jorgensen J, Nolan BW, Bertges DJ, Likosky DS,
Cronenwett JL. A regional quality improvement effort to increase beta
blocker administration before vascular surgery. J Vasc Surg 2011.
9. Cronenwett JL, Likosky DS, Russell MT, Eldrup-Jorgensen J, Stanley
AC, Nolan BW. A regional registry for quality assurance and improve-
ment: the Vascular Study Group of Northern New England
(VSGNNE). J Vasc Surg 2007;46:1093-101; Discussion:101-2.
0. Conte MS. Understanding objective performance goals for critical limb
ischemia trials. Semin Vasc Surg 2010;23:129-37.
1. Conte MS, Geraghty PJ, Bradbury AW, et al. Suggested objective
performance goals and clinical trial design for evaluating catheter-based
treatment of critical limb ischemia. J Vasc Surg 2009;50:1462-73 e1-3.
2. University Health Consortium. Available at: https://www.uhc.edu/
11851.htm.
3. Goodney PP, Eldrup-Jorgensen J, Nolan BW, Bertges DJ, Likosky DS,
Cronenwett JL, et al. A regional quality improvement effort to increase
beta blocker administration before vascular surgery. J Vasc Surg 2011;
53:1316-28 e1; discussion 27-8.
4. Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, Conte
MS. Statins are independently associated with reduced mortality in
patients undergoing infrainguinal bypass graft surgery for critical limb
ischemia. J Vasc Surg 2008;47:774-81.
5. Ricotta JJ, Aburahma A, Ascher E, Eskandari M, Faries P, Lal BK.
Updated Society for Vascular Surgery guidelines for management of
extracranial carotid disease. J Vasc Surg 2011;54:e1-31.
6. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin
JL, et al. ACC/AHA 2005 guidelines for the management of patients
with peripheral arterial disease (lower extremity, renal, mesenteric, and
abdominal aortic): executive summary a collaborative report from the
American Association for Vascular Surgery/Society for Vascular Sur-
gery, Society for Cardiovascular Angiography and Interventions, Soci-
ety for Vascular Medicine and Biology, Society of Interventional Radi-
ology, and the ACC/AHA Task Force on Practice Guidelines (Writing
Committee to Develop Guidelines for the Management of Patients
With Peripheral Arterial Disease) endorsed by the American Association
of Cardiovascular and Pulmonary Rehabilitation; National Heart,
Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic
Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll
Cardiol 2006;47:1239-312.ubmitted Sep 19, 2011, accepted Oct 26, 2011.
